Medigen Biotechnology (3176) — Working Capital to Net Assets Ratio
Medigen Biotechnology (3176) has a Working Capital to Net Assets ratio of 58.4% as of September 2025. Working capital of NT$2.86 Billion (current assets of NT$3.55 Billion minus current liabilities of NT$694.25 Million) is measured against net assets of NT$4.90 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Medigen Biotechnology defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medigen Biotechnology Working Capital to Net Assets (2015–2024)
This chart shows how Medigen Biotechnology's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the ratio stands at 58.4%, reflecting working capital of NT$2.86 Billion against net assets of NT$4.90 Billion TWD. For the complete balance sheet picture, see Medigen Biotechnology asset portfolio.
Annual Working Capital to Net Assets for Medigen Biotechnology (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medigen Biotechnology from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Medigen Biotechnology to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 54.3% | NT$2.74 Billion | NT$5.04 Billion | NT$3.66 Billion | NT$925.22 Million | ▼ -4.3 pp |
| 2023 | 58.6% | NT$2.93 Billion | NT$5.00 Billion | NT$5.71 Billion | NT$2.78 Billion | ▼ -29.2 pp |
| 2022 | 87.8% | NT$5.68 Billion | NT$6.47 Billion | NT$6.73 Billion | NT$1.05 Billion | ▲ +27.8 pp |
| 2021 | 60.0% | NT$3.85 Billion | NT$6.43 Billion | NT$4.92 Billion | NT$1.06 Billion | ▲ +13.6 pp |
| 2020 | 46.4% | NT$2.09 Billion | NT$4.50 Billion | NT$3.02 Billion | NT$933.80 Million | ▲ +32.2 pp |
| 2019 | 14.2% | NT$381.67 Million | NT$2.69 Billion | NT$1.31 Billion | NT$930.46 Million | ▼ -16.1 pp |
| 2018 | 30.3% | NT$891.54 Million | NT$2.94 Billion | NT$1.56 Billion | NT$665.11 Million | ▲ +4.5 pp |
| 2017 | 25.8% | NT$821.53 Million | NT$3.18 Billion | NT$1.61 Billion | NT$792.75 Million | ▲ +3.0 pp |
| 2016 | 22.8% | NT$806.45 Million | NT$3.54 Billion | NT$1.35 Billion | NT$547.46 Million | ▼ -11.1 pp |
| 2015 | 33.9% | NT$1.17 Billion | NT$3.46 Billion | NT$1.51 Billion | NT$333.17 Million | — |